Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Aspart Effects on Platelet Activation in T2DM
NCT00771693Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2007
- Primary completion
- Jul 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Karolinska Institutet. Started May 2007; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00771693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771693.